Company / Depreciation & Amortization
Oruka Therapeutics, Inc. Depreciation & Amortization History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$27.0K
FY2024
5-year range
$8.0K / $27.0K
FY2020-FY2024
Trend
+80.0%
vs FY2023
Sector context
#161 of 163
Health Care
What the data says
Among 163 Health Care companies, Oruka Therapeutics, Inc. is in the top 1% for depreciation & amortization. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $8,000 in FY2021 to $27,000 in FY2024.
Based on SEC 10-K filings.
$27,000 in FY2024 with a 5-year CAGR of +4.2%.
Increased from $16,000 to $27,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +50.0%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 80.0% year-over-year.
- Ranks #161 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $27.0K | +80.0% |
| FY2023 | $15.0K | -6.3% |
| FY2022 | $16.0K | +100.0% |
| FY2021 | $8.0K | -55.6% |
| FY2020 | $18.0K | -18.2% |
| FY2019 | $22.0K | -18.5% |
| FY2018 | $27.0K | +12.5% |
| FY2017 | $24.0K | +26.3% |
| FY2016 | $19.0K | +58.3% |
| FY2015 | $12.0K | -53.8% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026